PEANUT ALLERGY
Clinical trials for PEANUT ALLERGY explained in plain language.
Never miss a new study
Get alerted when new PEANUT ALLERGY trials appear
Sign up with your email to follow new studies for PEANUT ALLERGY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could this shot train your body to handle peanuts?
Disease control Not yet recruitingThis early-stage study is testing a new injection called UKK-0018 in adults with peanut allergies. The goal is to see if the treatment is safe and if it can help the immune system become less reactive to peanuts over time. Researchers will give the injections to 40 participants a…
Matched conditions: PEANUT ALLERGY
Phase: PHASE1, PHASE2 • Sponsor: Ukko Inc • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
New drug trial aims to tame peanut allergies
Disease control Not yet recruitingThis study is testing if a drug called tezepelumab can make a standard peanut allergy treatment more effective. It will involve 62 people aged 12-55 with a confirmed peanut allergy. The goal is to see if the drug helps people build a lasting tolerance to peanut protein, even afte…
Matched conditions: PEANUT ALLERGY
Phase: PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
Heat-Treated peanuts may offer safer allergy therapy
Disease control Not yet recruitingThis study is testing whether using heat-treated (autoclaved) peanuts causes fewer allergic reactions during oral immunotherapy compared to regular peanuts. Children and adults aged 4-30 with confirmed peanut allergy will receive small, gradually increasing amounts of one type of…
Matched conditions: PEANUT ALLERGY
Phase: PHASE2 • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control
Last updated Mar 18, 2026 14:40 UTC